FAQ: Childhood Maltreatment Linked to Higher Risk of Psoriasis and Rheumatoid Arthritis
Summary
A study in Heliyon reveals a significant link between childhood maltreatment and an increased risk of developing chronic immune-related disorders like psoriasis and rheumatoid arthritis later in life, with women being more susceptible.
What is the main finding of the study mentioned?
The study found that individuals who experienced neglect, abuse, or other forms of maltreatment during childhood have a notably elevated risk of being diagnosed with chronic immune-related disorders, specifically psoriasis and rheumatoid arthritis, later in life.
Where were the findings of the study published?
The findings appeared in the journal Heliyon.
Who is more likely to develop these immune disorders according to the study?
Women exhibited a higher likelihood of developing psoriasis and rheumatoid arthritis as a result of childhood maltreatment.
Why is this study important?
This study highlights the long-term health impacts of childhood maltreatment, emphasizing the need for more effective treatments and interventions to manage or prevent chronic immune-related disorders in affected individuals.
What are the chronic immune-related disorders noted in the study?
Psoriasis and rheumatoid arthritis were particularly noted in the study subjects.
What is being done to address the findings of this study?
Enterprises like Soligenix Inc. are focused on developing more effective treatments to help manage symptoms of these disorders. More studies are also being conducted to understand why certain people develop immune-related disorders.
Where can I read more about this study?
You can read more about the study here.
What is BioMedWire?
BioMedWire is a specialized communications platform focusing on the latest developments in the Biotechnology, Biomedical Sciences, and Life Sciences sectors, providing access to a vast network of wire solutions and other corporate communications services.
How can I receive alerts from BioMedWire?
To receive SMS alerts from BioMedWire, text ‘Biotech’ to 888-902-4192 (U.S. Mobile Phones Only).
Where can I find more information about BioMedWire?
For more information, please visit https://www.BioMedWire.com.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 119327